Back to results
US 10,035,849 B2Granted
Methods and compositions for targeting polyubiquitin
AssigneeGenentech, Inc.
InventorsRobert F. Kelley, Marissa Matsumoto
Life of this patent
Estimating the term…
Abstract
Anti-K63-linked polyubiquitin monoclonal antibodies, and methods for using the antibodies, are provided.
Claims23
An isolated antibody or antigen-binding fragment thereof that specifically binds to K63-linked polyubiquitin, comprising:
- the HVR-H1 sequence of SEQ ID NO:
- 5;
- the HVR-H2 sequence of SEQ ID NO:
- 61, optionally having one substitution selected from the following:
- (i) a D at position 1,
- (ii) an A at position 3,
- (iii) a T at position 3, or
- (iv) an L at position 6;
- the HVR-H3 sequence of SEQ ID NO:
- 6;
- the HVR-L1 sequence of SEQ ID NO:
- 3;
- the HVR-L2 sequence of SEQ ID NO:
- 9, wherein:
- (a) if HVR-H2 is SEQ ID NO:
- 61, then HVR-L2 optionally has a substitution of an R at position 4,
- (b) if HVR-H2 is SEQ ID NO:
- 61 substituted with a D at position 1, then HVR-L2 optionally has a substitution of a A, S, or T at position 4 of SEQ ID NO:
- 9;
- (c) if HVR-H2 is SEQ ID NO:
- 61 substituted with an A at position 3, then HVR-L2 optionally has a substitution of an A, L, or N at position 4 of SEQ ID NO:
- 9;
- and
- (d) if HVR-H2 is SEQ ID NO:
- 61 substituted with a T at position 3, then HVR-L2 optionally has a substitution of a T at position 4 of SEQ ID NO:
- 9;
- and
- the HVR-L3 sequence of SEQ ID NO:
- 4.
26 more elements
Dependencies are inferred from the claim text.